RYTRAPDA Trademark

Trademark Overview

On Wednesday, June 14, 2017, a trademark application was filed for RYTRAPDA with the United States Patent and Trademark Office. The USPTO has given the RYTRAPDA trademark a serial number of 79213444. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, August 31, 2018. This trademark is owned by Merck KGaA. The RYTRAPDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use in the field of oncology
rytrapda

General Information

Serial Number79213444
Word MarkRYTRAPDA
Filing DateWednesday, June 14, 2017
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, August 31, 2018
Registration Number5430558
Registration DateTuesday, March 27, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use in the field of oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, May 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, June 15, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, June 15, 2018DEATH OF INTERNATIONAL REGISTRATION
Tuesday, March 27, 2018REGISTERED-PRINCIPAL REGISTER
Sunday, February 18, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, October 18, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 8, 2017REFUSAL PROCESSED BY IB
Friday, August 25, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 25, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 23, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 23, 2017REFUSAL PROCESSED BY MPU
Sunday, August 20, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 19, 2017NON-FINAL ACTION WRITTEN
Friday, August 18, 2017ASSIGNED TO EXAMINER
Friday, August 11, 2017APPLICATION FILING RECEIPT MAILED
Monday, August 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 4, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 3, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

rytrapda oncology field human preparations pharmaceutical